A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

Abstract Background Artemether–lumefantrine (AL) and artesunate–amodiaquine are first-line treatment for uncomplicated malaria in many endemic countries, including Mali. Dihydroartemisinin–piperaquine (DHA–PQ) is also an alternative first-line artemisinin-based combination therapy, but only few data...

Full description

Bibliographic Details
Main Authors: Souleymane Dama, Hamidou Niangaly, Moussa Djimde, Issaka Sagara, Cheick Oumar Guindo, Amatigue Zeguime, Antoine Dara, Abdoulaye A. Djimde, Ogobara K. Doumbo
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Malaria Journal
Subjects:
Dihydroartemisinin
Piperaquine
Artemether
Lumefantrine
In vivo
Online Access:http://link.springer.com/article/10.1186/s12936-018-2496-x

Internet

http://link.springer.com/article/10.1186/s12936-018-2496-x

Similar Items